Ruddy Deborah M, Parton Matthew J, Al-Chalabi Ammar, Lewis Cathryn M, Vance Caroline, Smith Bradley N, Leigh P Nigel, Powell John F, Siddique Teepu, Meyjes Eelco Postumus, Baas Frank, de Jong Vianney, Shaw Christopher E
Department of Medical and Molecular Genetics, Guy's, King's, and St. Thomas' School of Medicine, London, United Kingdom.
Am J Hum Genet. 2003 Aug;73(2):390-6. doi: 10.1086/377157. Epub 2003 Jul 1.
Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset disease in which motor neurons in the brain and spinal cord degenerate by largely unknown mechanisms. ALS is familial (FALS) in 10% of cases, and the inheritance is usually dominant, with variable penetrance. Mutations in copper/zinc super oxide dismutase (SOD1) are found in 20% of familial and 3% of sporadic ALS cases. Five families with ALS and frontotemporal dementia (ALS-FTD) are linked to 9q21, whereas one family with pure ALS is linked to 18q21. We identified two large European families with ALS without SOD1 mutations or linkage to known FALS loci and conducted a genomewide linkage screen using 400 microsatellite markers. In both families, two-point LOD scores >1 and a haplotype segregating with disease were demonstrated only across regions of chromosome 16. Subsequent fine mapping in family 1 gave a maximum two-point LOD score of 3.62 at D16S3137 and a three-point LOD score of 3.85 for markers D16S415 and D16S3137. Haplotype analysis revealed no recombination > approximately 30 cM, (flanking markers at D16S3075 and D16S3112). The maximum two-point LOD score for family 2 was 1.84 at D16S415, and the three-point LOD score was 2.10 for markers D16S419 and D16S415. Definite recombination occurred in several individuals, which narrowed the shared haplotype in affected individuals to a 10.1-cM region (flanking markers: D16S3396 and D16S3112). The region shared by both families on chromosome 16q12 corresponds to approximately 4.5 Mb on the Marshfield map. Bioinformatic analysis of the region has identified 18 known genes and 70 predicted genes in this region, and sequencing of candidate genes has now begun.
肌萎缩侧索硬化症(ALS)是一种成年发病的致命疾病,大脑和脊髓中的运动神经元会因 largely unknown mechanisms 而退化。10%的 ALS 病例为家族性(FALS),其遗传方式通常为显性,外显率可变。20%的家族性 ALS 病例和 3%的散发性 ALS 病例中发现了铜/锌超氧化物歧化酶(SOD1)突变。五个患有 ALS 和额颞叶痴呆(ALS-FTD)的家族与 9q21 相关联,而一个患有纯 ALS 的家族与 18q21 相关联。我们鉴定了两个没有 SOD1 突变或与已知 FALS 基因座无连锁关系的欧洲 ALS 大家族,并使用 400 个微卫星标记进行了全基因组连锁筛选。在这两个家族中,仅在 16 号染色体区域显示两点 LOD 得分>1 且单倍型与疾病共分离。随后在家族 1 中进行的精细定位在 D16S3137 处给出了最大两点 LOD 得分为 3.62,对于标记 D16S415 和 D16S3137 的三点 LOD 得分为 3.85。单倍型分析显示没有大于约 30 cM 的重组(侧翼标记为 D16S3075 和 D16S3112)。家族 2 的最大两点 LOD 得分在 D16S415 处为 1.84,对于标记 D16S419 和 D16S415 的三点 LOD 得分为 2.10。在几个个体中发生了明确的重组,这将受影响个体中的共享单倍型缩小到一个 10.1-cM 的区域(侧翼标记:D16S3396 和 D16S3112)。两个家族在 16q12 染色体上共享的区域在 Marshfield 图谱上对应于约 4.5 Mb。对该区域的生物信息学分析已鉴定出该区域中的 18 个已知基因和 70 个预测基因,目前已开始对候选基因进行测序。